The Tobias and Lechleiter families donated $20 million to establish the Institute for Clinical Innovation at IU Health, the ...

The stock market experienced quite a bit of volatility during President Donald Trump's first 100 days in office.

Real-time index price for S&P 500 Real Estate [Sector] (SRRE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

S&P Global, a financial-data firm, expects sales of Lilly’s obesity drugs to overtake Novo’s by 2027 (see chart 1). PREMIUM Eli-Lilly-looks-set-to-steal-Novo-Nordisk-s-weight Investors are ...

Eli Lilly is proving that being second ... Its share price has fallen by a third since the start of 2024; Lilly’s has risen by about as much (see chart 1). Chart: The Economist The momentum ...

Eli Lilly, the drugmaker behind the blockbuster weight loss drug Zepbound, is suing four telehealth companies for allegedly selling illegal copies of the drug made by compounding pharmacies.

Pharmaceutical giant Eli Lilly represents a powerful player in ... the printing of a possible bullish flag in the chart warrants caution for ELIS. Given current trends, it would not be surprising ...

Houston-based Empower Pharmacy is one of two compounding pharmacies sued by the pharmaceutical giant Eli Lilly earlier this month for allegedly selling "knockoff" versions of its weight loss and ...

Eli Lilly and Company, which already markets weight-loss and diabetes drugs that must be injected, is a step closer to introducing a once-daily pill for the same conditions. On April 17 ...